Subscribe to Newsletter
Subspecialties Oncology, Histology, Microbiology and immunology

Precise Spatial Multiplexing of Protein Biomarkers for Deep Immune Profiling of Tumors with ChipCytometry

sponsored by Canopy Biosciences

Available On-Demand

Thursday, 15th July, 2021. 11am EDT.


Understanding the complex spatial distribution of key immune cell populations in tumors is the next frontier in advancing our understanding of cancer to inform the development of novel therapeutics. Canopy Biosciences’ ChipCytometry platform combines iterative immuno-fluorescent staining with high dynamic range imaging to facilitate quantitative phenotyping with virtually unlimited protein biomarkers and true single-cell resolution. In this webinar, we will show how precise expression levels for each marker in each assay can be quantified for each individual cell in a sample, maintaining spatial information about each cell and uncovering new insights to the toughest questions in oncology and immuno-oncology.

Learning objectives:

  • Learn about the importance of high-plex spatial omics
  • Learn about the advantages of ChipCytometry

Available On-Demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Tumor Genomic Profiling with SureSelect Cancer Tumor-Specific Assays

| Contributed by Agilent

Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay

| Contributed by Agilent

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine